We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The leaders of the House health committee sent letters to three opioid distributors and the Drug Enforcement Administration, following news reports of large numbers of the painkillers being sold in West Virginia. Read More
PhRMA unveiled new criteria for membership, setting higher R&D requirements — and eliminating its associate member level entirely, which included 15 pharmaceutical companies. Read More
The FDA published draft revisions to its blueprint for educating health care providers about extended-release and long-acting opioid painkillers. Read More
Biosimilars consistently drive down average drug prices in markets where they are introduced, according to a report ordered by the European Commission. Read More
Merck Sharp & Dohme Corp. is settling its challenge over a Genentech patent on methods for artificially synthesizing antibodies, a process used for a variety of specialty medicines and cancer therapies. Read More
In yet another pressure point on generic drug prices, a class action suit filed in a Pennsylvania federal court claims Actavis, Teva, Sandoz, Fougera and Taro conspired to fix the prices of fluocinonide creams and gels. Read More